LONDONGlaxoSmithKline PLC Chief Executive Andrew Witty is under pressure Weak sales disappointing newdrug launches a profit warning and bribery allegations have helped cause a  slump in the drug makers shares this year as those of its rivals have gained ground I think the pressure on him has been building said Socit Gnrale analyst Stephen McGarry Some
  